Abstract
Background/Aim: We aimed to investigate the role of radiogenomic and deep learning approaches in predicting the KRAS mutation status of a tumor using radiotherapy planning computed tomography (CT) images in patients with locally advanced rectal cancer. Patients and Methods: After surgical resection, 30 (27.3%) of 110 patients were found to carry a KRAS mutation. For the radiogenomic model, a total of 378 texture features were extracted from the boost clinical target volume (CTV) in the radiotherapy planning CT images. For the deep learning model, we constructed a simple deep learning network that received a three-dimensional input from the CTV. Results: The predictive ability of the radiogenomic score model revealed an AUC of 0.73 for KRAS mutation, whereas the deep learning model demonstrated worse performance, with an AUC of 0.63. Conclusion: The radiogenomic score model was a more feasible approach to predict KRAS status than the deep learning model.
- Received June 1, 2021.
- Revision received June 21, 2021.
- Accepted June 22, 2021.
- Copyright © 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.